Interpretation of the key points of the 2022 White Paper on the Quality of Life of Chinese Lung Cancer Patients
- VernacularTitle:《2022年中国肺癌患者生存质量白皮书》要点解读
- Author:
Xiuyi ZHI
1
;
Jianguo SHI
2
,
3
;
Yantao TIAN
4
;
Ying HU
5
;
Xin WANG
6
;
Xiaobing YAO
7
;
Wengui LIU
8
Author Information
1. Department of Thoracic Surgery, Beijing Tsinghua Changgeng Hospital Affiliated to Tsinghua University, Tsinghua University School of Clinical Medicine, Beijing, 102218, P. R. China
2. Department of Oncology, Tangdu Hospital of Air Force Military Medical University, Xi&rsquo
3. an, 710032, P. R. China
4. Department of Pancreatogastric Surgery, Cancer Hospital of the Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
5. Beijing Chest Hospital Affiliated to Capital Medical University, Beijing, 101125, P. R. China
6. Cancer Hospital of the Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
7. Beijing Everbright Oriental Medical Research Institute, Beijing, 100085, P. R. China
8. Xiamen Cobble Network Technology Co., Ltd, Xiamen, 361008, Fujian, P. R. China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
disease onset;
prognosis;
disease burden
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(08):1083-1088
- CountryChina
- Language:Chinese
-
Abstract:
Recently, sponsored by the Science Popularization Department of the China Anti Cancer Association, jointly organized by the Rehabilitation Branch of the China Anti Cancer Association and the Mijian Digital Cancer Patient Course Management Platform, and co-organized by the Science Popularization Special Committee of the China Anti Cancer Association, The "2022 White Paper on the Quality of Life of Chinese Lung Cancer Patients" has been officially released (herein after referred to as the "White Paper"), which mainly elaborates on the basic situation of Chinese lung cancer patients and the medical, social, and economic impacts caused by the disease. This article interprets the White Paper in order to help the public understand the real situation of lung cancer patients and provide important empirical evidence and valuable insights for the diagnosis, treatment, and rehabilitation of lung cancer in China.
